Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-002-1
CAS number: 102-06-7
The result of the study showed that chronic exposure to
DPG stimulated pleen enlargement and that the rate of spleen enlargement
exponentially commensurated with in vivo and in vitro proliferation of
spleen cells. DNA synthesis, in response to DPG showed time-dependent
increases similar to spleen growth and cell proliferation kinetics.
Additionally, spleen cells from DPG-treated animals "modified" the
medium in which they were cultured and that when spleen cells from
control animals were incubated in these "modified" media., their rate of
proliferation almost approached that of the treated population. The
results of the study suggest that mouse spleen cells responded to direct
or indirect DPG treatment and that the mitogenic stimulus provided by
DPG paralleled increased DNA synthesis during and after exposure to the
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Esta web utiliza cookies para mejorar su experiencia de navegación en nuestros sitios web.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again